SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001213900-24-001961
Filing Date
2024-01-08
Accepted
2024-01-08 17:02:56
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea190535-f3_altamira.htm F-3 180650
2 OPINION OF CONYERS DILL & PEARMAN LIMITED, SPECIAL BERMUDA COUNSEL TO THE COMPAN ea190535ex5-1_altamira.htm EX-5.1 24747
3 CONSENT OF DELOITTE AG ea190535ex23-2_altamira.htm EX-23.2 2231
4 FILING FEE TABLE ea190535ex-fee_altamira.htm EX-FILING FEES 28863
5 GRAPHIC image_001.jpg GRAPHIC 4264
6 GRAPHIC ex5-1_001.jpg GRAPHIC 14208
  Complete submission text file 0001213900-24-001961.txt   263569
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-3 | Act: 33 | File No.: 333-276427 | Film No.: 24520935
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)